In comparison to C3 and C4, where levels represent the net rate of production and consumption, this assay measures a cleavage neoepitope solely exposed during complement activation and it has proven valuable as a biomarker in another autoimmune disease [35, 36]. This evidence concerns the gene C3 and autoimmune disease.